You Searched For "stephane bancel" and got 20 results
Sort By:
2 mins read
After Moderna chief, Pfizer CEO says COVID-19 likely to end in a year
"Within a year I think we will be able to come back to normal life," Bourla was quoted as saying…
PTI
2 mins read
Moderna gets additional $472 million from US for Covid-19 vaccine trial
Pharmaceutical company Moderna has received an additional $472 million award from the US government…
1 min read
Meet Stephane Bancel, the CEO of Moderna, a company developing a coronavirus vaccine in record time, who just became a billionaire
Do you have a personal experience with the coronavirus you'd like to share? Or a tip on how your to…
Joey Hadden
1 min read
Moderna stock tumbles 21% as earnings show people aren't getting as many COVID shots
Moderna lowered its annual sales forecast as sales of its COVID-19 vaccine dropped by 37%, fueled b…
Kelly Cloonan
2 mins read
Billionaires and corporate execs have dumped $9 billion worth of stock this year amid the market's latest rally
Big-name investors have moved quickly to dump stock shares amid this year's rally, with the S&P 500…
Jennifer Sor
1 min read
Moderna CEO says he'll give away most of his estimated $4.1 billion fortune
Stephane Bancel, Moderna's CEO, said at the World Economic Forum he is planning to donate the bulk …
Beatrice Nolan
1 min read
Moderna CEO says people may need a fourth Covid vaccine jab this coming fall as the efficacy of the current booster likely wanes over time
Boosters will likely protect people through the current Omicron surge, Moderna's Stephane Bancel sa…
Huileng Tan
2 mins read
Moderna says its booster significantly increases antibody levels against the Omicron variant
Moderna shared new data which shows that a 50-microgram dose of its booster vaccine increases the l…
Mary Hanbury
2 mins read
Moderna's CEO sold nearly $2 million of his stock ahead of the company's emergency use vaccine filing. He's now worth $3 billion.
Bancel sold a total of 19,000 shares between November 18-19 as part of a predetermined trading plan…
Shalini Nagarajan
1 min read
Meet Insider's 30 leaders under 40 transforming healthcare
These are Insider's biggest healthcare stories for August 16.
Lydia Ramsey Pflanzer
1 min read
Moderna Covid-19 vaccine to cost govts $25-$37 per dose: CEO
Bancel said that the price he quoted was a "fair price" and that the company was not interested …
1 min read
The pandemic has disrupted childhood vaccinations, dropping by 11 million doses in the past year: CDC director
As government officials work to get children back to school, CDC tells parents to make sure their c…
Bre'Anna Grant
2 mins read
The Omicron variant could throw the booming economic recovery off the rails, Fed Chair Powell says
Even if the variant is less of a health risk than Delta, public concern could hammer the recovery a…
Ben Winck
2 mins read
Moderna just finished recruiting 30,000 people for its coronavirus vaccine trial. One graph reveals how the biotech slowed down its research to recruit more minorities.
Minorities make up 37% of the study, but that percentage was on track to be much lower until the co…
Andrew Dunn
2 mins read
Moderna CEO says data on the Covid-19 vaccine in young children likely won't be available until 2022
Moderna will begin studying the Covid-19 vaccine in young children soon, but data won't be availabl…
Natasha Dailey
2 mins read
US stocks extend losses as new tapering comments from Fed Chair Powell stoke rate-hike concern
Powell also remarked on Tuesday that inflation no longer warrants the "transitory" label.
Isabelle Lee
4 mins read
Moderna's potential coronavirus vaccine just got a huge funding boost from the US government
The study is designed to focus on the vaccine's safety in humans, as well as if it can provoke an i…
Andrew Dunn
2 mins read
The inside story of how the $10 billion biotech Moderna developed a potential coronavirus vaccine in record time
Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Valu…
Andrew Dunn
4 mins read
The CEO of the buzzy biotech that's working on a potential coronavirus vaccine just pledged he won't set a high price for the shot
Even with the long road ahead, Moderna has beaten history in the race to construct a potential vacc…